KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SemiLEDs (LEDS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for SemiLEDs (LEDS) over the last 17 years, with Q4 2025 value amounting to $2.9 million.

  • SemiLEDs' Cash & Equivalents rose 14166.67% to $2.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $2.9 million, marking a year-over-year increase of 14166.67%. This contributed to the annual value of $2.6 million for FY2025, which is 5517.65% up from last year.
  • Latest data reveals that SemiLEDs reported Cash & Equivalents of $2.9 million as of Q4 2025, which was up 14166.67% from $2.6 million recorded in Q3 2025.
  • SemiLEDs' 5-year Cash & Equivalents high stood at $4.5 million for Q4 2022, and its period low was $190000.0 during Q3 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $2.3 million (2022), whereas its average is $2.4 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9142.21% in 2023, then surged by 77947.37% in 2024.
  • Quarter analysis of 5 years shows SemiLEDs' Cash & Equivalents stood at $4.1 million in 2021, then increased by 9.76% to $4.5 million in 2022, then crashed by 48.89% to $2.3 million in 2023, then crashed by 47.83% to $1.2 million in 2024, then soared by 141.67% to $2.9 million in 2025.
  • Its Cash & Equivalents stands at $2.9 million for Q4 2025, versus $2.6 million for Q3 2025 and $2.4 million for Q2 2025.